NeuroVenti contributes to creating a society where we work together.

NeuroVenti strives to create a society of brain wellness.

We are NeuroVenti, Inc., an innovative biotech startup company developing small molecule drugs against neurodevelopmental conditions, such as autism spectrum disorders(ASD) and syndromic ASD-like fragile X syndrome. Our pipeline includes multi-target drugs which can be applied for phase II clinical trials. We also provide CDRO(Clinical Development and Research Organization) services, including drug discovery, pre-clinical evaluation of efficacy and safety for candidate molecules targeting CNS (neurological, psychiatric, and neurodevelopmental) disorders.
Drug Development Drug Development
  • 1Neurodevelopmental disorders
    • Autism spectrum disorder (ASD)
    • ADHD
  • 2Intractable brain disease
뇌질환 치료제 후보발굴 서비스 CNS disorders’
therapeutic candidates research service
  • 1Preclinical research consulting
  • 2CNS disease-related research service
  • 3One-stop in vitro & in vivo efficacy test
Platform technology Platform technology
  • 1Precision medicine
  • 2Electroceuticals
  • 3Health care solution